Open AccessPlanning the hepatitis C virus elimination in Cyprus: A modeling study
Author(s) -
Ilias Gountas,
Ioanna Yiasemi,
Evi Kyprianou,
Christos Mina,
Chrysanthos Georgiou,
Petros Katsioloudes,
Andri Kouroufexi,
Anna Demetriou,
Elena Xenofontos,
Georgios K. Nikolopoulos
Publication year - 2021
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v27.i31.5219
Subject(s) - virology , hepatitis c virus , hepacivirus , medicine , virus
Hepatitis C virus (HCV) infection is a major global public health problem. In the Republic of Cyprus, the estimated prevalence of chronic hepatitis C (CHC) among the general population is 0.6%, while the CHC prevalence among people who inject drugs (PWID) is estimated at 46%. Direct-acting antivirals that can eliminate HCV are not yet widely available in the Republic of Cyprus. However, when direct-acting antivirals become available, a long-term strategic plan to guide elimination efforts will be needed to maximize the effect of treatment.